The Centers for Disease Control and Prevention today identified vitamin E acetate as a “potential chemical of concern” in biologic samples from patients with vaping-associated lung injuries. The agency tested lung fluid samples from 29 patients with the condition (called EVALI) in 10 states and found vitamin E acetate in all 29 samples. “These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs,” CDC said. It also found tetrahydrocannabinol (THC) in 82% of the samples and nicotine in 62% of the samples. CDC yesterday updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 2,051 in 49 states, the District of Columbia and the U.S. Virgin Islands, including 39 confirmed deaths. CDC and the Food and Drug Administration continue to investigate the cause of the illness, and encourage health care providers to report possible cases to their state or local health department.

Related News Articles

Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier…
Headline
Josh Neff, CEO of CommonSpirit Mercy Hospital, discusses a new cutting-edge communication platform that sends patient EKGs directly from the ambulance to the…
Headline
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by…
Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…